It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the studies performed, to reach their recommendations on how to use the medicine.
Selles selgitatakse, kuidas inimravimikomitee hindas tehtud uuringuid, et koostada ravimi kasutamise soovitused.